| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9346275 | Ophthalmology | 2005 | 7 Pages |
Abstract
After 1 year of follow-up, the silicone AGV is at least as effective as the polypropylene AGV in IOP reduction but may be associated with a higher rate of complications. These differences are important for surgeons converting to use of the silicone AGV in patients with glaucoma refractory to other forms of treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Simon K. MD, Anne BS, Anne L. MD, PhD, Joseph MD,